DE69938579D1 - Extrazelluläre Matrixproteine mit modifizierten Aminosäuren - Google Patents

Extrazelluläre Matrixproteine mit modifizierten Aminosäuren

Info

Publication number
DE69938579D1
DE69938579D1 DE69938579T DE69938579T DE69938579D1 DE 69938579 D1 DE69938579 D1 DE 69938579D1 DE 69938579 T DE69938579 T DE 69938579T DE 69938579 T DE69938579 T DE 69938579T DE 69938579 D1 DE69938579 D1 DE 69938579D1
Authority
DE
Germany
Prior art keywords
amino acids
extracellular matrix
modified amino
matrix proteins
proteins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69938579T
Other languages
English (en)
Other versions
DE69938579T2 (de
Inventor
Elliott A Gruskin
Douglas D Buechter
Guanghui Zhang
Kevin Connolly
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
United States Surgical Corp
Original Assignee
United States Surgical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by United States Surgical Corp filed Critical United States Surgical Corp
Publication of DE69938579D1 publication Critical patent/DE69938579D1/de
Application granted granted Critical
Publication of DE69938579T2 publication Critical patent/DE69938579T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/75—Fibrinogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4725—Proteoglycans, e.g. aggreccan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/495—Transforming growth factor [TGF]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69938579T 1998-10-09 1999-10-07 Extrazelluläre Matrixproteine mit modifizierten Aminosäuren Expired - Lifetime DE69938579T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US169768 1998-10-09
US09/169,768 US6492508B1 (en) 1996-06-03 1998-10-09 Nucleic acids encoding extracellular matrix proteins

Publications (2)

Publication Number Publication Date
DE69938579D1 true DE69938579D1 (de) 2008-06-05
DE69938579T2 DE69938579T2 (de) 2009-06-04

Family

ID=22617093

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69938579T Expired - Lifetime DE69938579T2 (de) 1998-10-09 1999-10-07 Extrazelluläre Matrixproteine mit modifizierten Aminosäuren

Country Status (5)

Country Link
US (3) US6492508B1 (de)
EP (2) EP0992586B1 (de)
CA (4) CA2284397C (de)
DE (1) DE69938579T2 (de)
ES (1) ES2303364T3 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6927287B1 (en) * 1996-06-03 2005-08-09 United States Surgical Corporation Nucleic acid encoding extracellular matrix protein or fragment thereof
CA2358517C (en) 1999-01-06 2012-10-09 University Of Southern California Method and composition for angiogenesis inhibition
WO2001004157A2 (en) 1999-07-13 2001-01-18 University Of Southern California NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS
FR2807436B1 (fr) * 2000-04-10 2002-05-24 Meristem Therapeutics Methode d'obtention de fibres d'un polypeptide collagenique recombinant non-hydroxyle, et fibres de polypeptide collagenique recombinant non-hydroxyle ainsi obtenues
WO2003035692A2 (en) * 2001-10-23 2003-05-01 The Victoria University Of Manchester Modified peptides and their uses
US7365167B2 (en) 2001-11-26 2008-04-29 Cell Matrix, Inc. Humanized collagen antibodies and related methods
US7390885B2 (en) 2001-11-26 2008-06-24 Cell Matrix, Inc. Humanized collagen antibodies and related methods
KR20050010778A (ko) * 2002-05-03 2005-01-28 밀레늄 바이올로직스 인코포레이티드 결합조직 자극 펩티드
WO2006130190A2 (en) * 2005-02-07 2006-12-07 Dickman Martin B Proline suppresses apoptosis
US10183986B2 (en) 2005-12-15 2019-01-22 Industrial Technology Research Institute Trimeric collagen scaffold antibodies
US20110177524A1 (en) * 2008-07-09 2011-07-21 Profibrix Bv Recombinant Fibrinogen
WO2010071938A1 (en) * 2008-12-24 2010-07-01 Commonwealth Scientific And Industrial Research Organisation Novel collagen constructs
WO2011065940A1 (en) 2009-11-24 2011-06-03 Biogen Idec Ma Inc. Method of supplementing culture media to prevent undesirable amino acid substitutions
EP2876165A1 (de) 2013-11-22 2015-05-27 ACIB GmbH Verbessertes Verfahren zur Herstellung modifizierter Target-Polypeptide

Family Cites Families (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US495527A (en) * 1893-04-18 Game apparatus
US4066658A (en) 1975-08-11 1978-01-03 Hoffmann-La Roche Inc. Resolution of d,l-dehydroproline
US4294753A (en) 1980-08-04 1981-10-13 The Regents Of The University Of California Bone morphogenetic protein process
US4761471A (en) 1980-08-04 1988-08-02 The Regents Of The University Of California Bone morphogenetic protein composition
US4789732A (en) 1980-08-04 1988-12-06 Regents Of The University Of California Bone morphogenetic protein composition
US4455226A (en) 1980-12-22 1984-06-19 Solmat Systems, Ltd. Method and apparatus for treating the surface of a body of liquid
US4472840A (en) 1981-09-21 1984-09-25 Jefferies Steven R Method of inducing osseous formation by implanting bone graft material
US4434094A (en) 1983-04-12 1984-02-28 Collagen Corporation Partially purified osteogenic factor and process for preparing same from demineralized bone
US4804744A (en) 1984-01-04 1989-02-14 International Genetic Engineering, Inc. Osteogenic factors
US4526909A (en) 1984-01-09 1985-07-02 Regents Of The University Of California Polymethylmethacrylate delivery system for bone morphogenetic protein
US4563489A (en) 1984-02-10 1986-01-07 University Of California Biodegradable organic polymer delivery system for bone morphogenetic protein
US4608199A (en) 1984-03-20 1986-08-26 Arnold Caplan Bone protein purification process
US4596574A (en) 1984-05-14 1986-06-24 The Regents Of The University Of California Biodegradable porous ceramic delivery system for bone morphogenetic protein
EP0169016B2 (de) 1984-07-16 2004-04-28 Celtrix Pharmaceuticals, Inc. Knorpel-induzierende Polypeptid-Faktoren aus Knochen
US4843063A (en) 1984-07-16 1989-06-27 Collagen Corporation Polypeptide cartilage-inducing factors found in bone
US4627982A (en) 1984-07-16 1986-12-09 Collagen Corporation Partially purified bone-inducing factor
US4563350A (en) 1984-10-24 1986-01-07 Collagen Corporation Inductive collagen based bone repair preparations
US4681763A (en) 1985-06-11 1987-07-21 University Of Medicine And Dentistry Of New Jersey Composition for stimulating bone growth
JPH0662679B2 (ja) 1985-06-21 1994-08-17 新田ゼラチン株式会社 組織親和性コラ−ゲンとその製法
US4725234A (en) 1985-08-15 1988-02-16 Ethridge Edwin C Alveolar bone grafting process with controlled surface active ceramics
US4798885A (en) 1986-02-07 1989-01-17 Genentech, Inc. Compositions of hormonally active human and porcine inhibin containing an α chain and 62 chain
US4737578A (en) 1986-02-10 1988-04-12 The Salk Institute For Biological Studies Human inhibin
US5108922A (en) 1986-07-01 1992-04-28 Genetics Institute, Inc. DNA sequences encoding BMP-1 products
ZA874681B (en) 1986-07-01 1988-04-27 Genetics Inst Novel osteoinductive factors
US5106748A (en) 1986-07-01 1992-04-21 Genetics Institute, Inc. Dna sequences encoding 5 proteins
US5187076A (en) 1986-07-01 1993-02-16 Genetics Institute, Inc. DNA sequences encoding BMP-6 proteins
US5013649A (en) 1986-07-01 1991-05-07 Genetics Institute, Inc. DNA sequences encoding osteoinductive products
DE286239T1 (de) 1987-03-10 1994-02-24 New England Biolabs Inc Herstellung und Reinigung eines Proteins, das mit einem Bindungsprotein fusioniert ist.
IT1214505B (it) 1987-03-12 1990-01-18 Gentili Ist Spa Procedimento per la preparazione di collageno e prodotti cosi'ottenuto.
CA1339083C (en) 1987-11-13 1997-07-29 Steven R. Jefferies Bone repair material and delayed drug delivery system
US4857476A (en) 1988-01-26 1989-08-15 Hewlett-Packard Company Bipolar transistor process using sidewall spacer for aligning base insert
IL89869A0 (en) 1988-04-06 1989-12-15 Collagen Corp Bone-inducing protein
ATE231523T1 (de) 1988-04-08 2003-02-15 Stryker Corp Osteogene vorrichtungen
US5250302A (en) 1988-04-08 1993-10-05 Stryker Corporation Osteogenic devices
US4968590A (en) 1988-04-08 1990-11-06 Stryker Corporation Osteogenic proteins and polypeptides
US5011691A (en) 1988-08-15 1991-04-30 Stryker Corporation Osteogenic devices
EP0449839A1 (de) 1988-09-30 1991-10-09 AlliedSignal Inc. Bakterielle stämme zur heterologen genexpression
US5106626A (en) 1988-10-11 1992-04-21 International Genetic Engineering, Inc. Osteogenic factors
US4891359A (en) 1988-12-08 1990-01-02 Johnson & Johnson Patient Care, Inc. Hemostatic collagen paste composition
AU5654990A (en) 1989-04-28 1990-11-29 Brigham And Women's Hospital Novel materials and methods for guided tissue regeneration
CA2017466A1 (en) 1989-06-02 1990-12-02 Michael C. Kiefer Bone calcification factor
CA2020729A1 (en) 1989-07-19 1991-01-20 Michael C. Kiefer Bone morphogenetic protein
JPH05500503A (ja) 1989-08-21 1993-02-04 セルトリックス　ファーマシューティカルズ、インコーポレイテッド 骨特異的タンパク質
US5358857A (en) 1989-08-29 1994-10-25 The General Hospital Corp. Method of preparing fusion proteins
DE69027961T2 (de) 1989-09-06 1997-01-09 Chichibu Onoda Cement Corp Protein, DNA und ihre Verwendung
DK0448704T3 (da) 1989-10-17 1999-04-06 Stryker Corp Osteogene anordninger
DE69131574T2 (de) 1990-05-14 2000-05-04 Gary R. Jernberg Chirurgisches implantat und verfahren zum einbetten von chemotherapeutika
US5168050A (en) 1990-05-24 1992-12-01 Genentech, Inc. Mammalian expression of the bone morphogenetic protein-2b using bmp2a/bmp2b fusion
ATE253589T1 (de) 1990-09-26 2003-11-15 Inst Genetics Llc Bmp-5-derivate
ES2087207T3 (es) 1990-11-23 1996-07-16 American Cyanamid Co Factor del crecimiento de fibroblasto quimerico.
US5208219A (en) 1991-02-14 1993-05-04 Celtrix Pharmaceuticals Inc. Method for inducing bone growth
US5118667A (en) 1991-05-03 1992-06-02 Celtrix Pharmaceuticals, Inc. Bone growth factors and inhibitors of bone resorption for promoting bone formation
CA2102808A1 (en) 1991-05-10 1992-11-11 Hanne Bentz Targeted delivery of bone growth factors
CZ282231B6 (cs) 1991-06-05 1997-06-11 The Procter And Gamble Company Prostředek na generování nového růstu kosti v savci
US5593859A (en) 1991-10-23 1997-01-14 Thomas Jefferson University Synthesis of human procollagens and collagens in recombinant DNA systems
AU663328B2 (en) 1991-06-21 1995-10-05 Genetics Institute, Llc Pharmaceutical formulations of osteogenic proteins
KR100255415B1 (ko) 1991-06-25 2000-05-01 브루스 엠. 에이센 비엠피-9 조성물
US5171579A (en) 1991-10-11 1992-12-15 Genetics Institute, Inc. Formulations of blood clot-polymer matrix for delivery of osteogenic proteins
JP2829405B2 (ja) 1991-10-14 1998-11-25 寳酒造株式会社 機能性ポリペプチド
US5667839A (en) * 1993-01-28 1997-09-16 Collagen Corporation Human recombinant collagen in the milk of transgenic animals
EP0759762A4 (de) * 1994-05-02 1999-09-01 Squibb & Sons Inc Rekombinante fibrinketten, fibrin und fibrinhomologe
DE69528128T2 (de) * 1994-06-10 2003-03-13 United States Surgical Corp., Norwalk Rekombinante Chimäre Proteine und Verfahren zur deren Verwendung
WO1997004123A1 (en) * 1995-07-19 1997-02-06 Gel Tech Group Inc. Collagen compound production in plants
AU3056697A (en) * 1996-04-12 1997-11-07 Academy Of Finland Synthesis of human procollagens and collagens in recombinant dna systems
US5821089A (en) 1996-06-03 1998-10-13 Gruskin; Elliott A. Amino acid modified polypeptides
US6428978B1 (en) * 1998-05-08 2002-08-06 Cohesion Technologies, Inc. Methods for the production of gelatin and full-length triple helical collagen in recombinant cells
WO2000014201A1 (en) * 1998-09-09 2000-03-16 United States Surgical Corporation Polypeptides containing modified, non-natural amino acids and methods of production

Also Published As

Publication number Publication date
CA2639757A1 (en) 2000-04-09
EP0992586A2 (de) 2000-04-12
US6958223B2 (en) 2005-10-25
CA2639637A1 (en) 2000-04-09
CA2284397C (en) 2008-12-16
DE69938579T2 (de) 2009-06-04
EP0992586A3 (de) 2004-04-21
CA2284397A1 (en) 2000-04-09
US20050196830A1 (en) 2005-09-08
US20040086961A1 (en) 2004-05-06
CA2639620A1 (en) 2000-04-09
US6492508B1 (en) 2002-12-10
EP0992586B1 (de) 2008-04-23
ES2303364T3 (es) 2008-08-01
EP1914311A1 (de) 2008-04-23

Similar Documents

Publication Publication Date Title
FI953837A (fi) Synteettisiä aktivoituvia aminohappoja
DE59813840D1 (de) Protein mit phospholipaseaktivität
NO20001242D0 (no) April - et nytt protein med veksteffekter
DE69826639D1 (de) Chirurgische artikel hergestellt aus polyesteramiden mit von aminosäuren abstammenden gruppen und dazu alternierend mit von alpha-hydroxysäuren abstammenden gruppen
DK1049788T3 (da) Proteinekspression i baculovirus-vektorekspressionssystemer
NO20002990L (no) Nytt overflateprotein
NO20000700D0 (no) Interleukin-18-proteiner samt fremstilling og anvendelse derav
ATE225776T1 (de) Bicyclische aromatische aminosäuren
ATE238984T1 (de) Sulfonylaminocarbonsäuren
ATE259349T1 (de) Neue aminosäurederivate mit verbesserter multidrogenresistenz-aktivität
DE69938579D1 (de) Extrazelluläre Matrixproteine mit modifizierten Aminosäuren
DE60328469D1 (de) Aminosäuren mit affinität zu alpha-2-delta-protein
DE19882020D2 (de) Thermo-optischer Schalter mit seitlich versetzten Element
ATE230926T1 (de) Synergistische mischungen von ausgewählten aminosäuren
NO980566D0 (no) Allergen-XCD32 fusjonsproteiner
MX219629B (es) Metodo para separar proteinas de fusion
ZA98642B (en) Immune-modulation with amino acids
NO20021275D0 (no) Transgent produserte fusjonsproteiner
DE60040903D1 (de) Aminosäuren enthaltende albuminpräparationen
DE69823225D1 (de) Fusionsproteine, bestehend aus proteinaseinhibitoren
NO980375D0 (no) Humant MP52 Arg protein
FI971085A0 (fi) Uusia PKA:ta sitovia proteiineja ja näiden käyttömuotoja
NO20005547D0 (no) Myelinbasiske proteinpeptider og anvendelser derav
NO20021244D0 (no) Subenhet-optimaliserte fusjonsproteiner
ATA114093A (de) Markierte alpha aminosäuren

Legal Events

Date Code Title Description
8364 No opposition during term of opposition